* Fast-track promotion within 2 years to the position of Manager

* Fast-track promotion within 9 months of joining after having secured highest performance rating* Valuation of a beauty and personal care company for the purpose of proposed capital reduction * Purchase price allocation of a banking business of a foreign company acquired by one of the big banking houses in India* Purchase price allocation of an health insurance company* Determination of share exchange ratio for the proposed merger of Butterfly Gandhimathi into Crompton Greaves* Valuation of an asset reconstruction company (ARC) for FEMA and Tax purposes * Valuation of two NBFCs (primarily in lending for vehicle financing) for the purpose of proposed transfer of lending business on slump sale basis* Valuation under FEMA and Rule 11UA of 6 SPVs engaged in the business of operating and maintaining roads/highways (HAM and BOT revenue models)* Valuation of AI and analytics company that had become an unicorn in January 2022* Value analysis of a Bangladesh FMCG company which was a potential target of a large listed FMCG company in India* Valuation of OTT business housed within India's biggest corporate groups* Purchase price allocation of a solar power plant company acquired by one of India's largest conglomerate* Acting as auditor's expert in valuing portfolio entities of a Singapore based PE fund focused toward investing in early stage companies engaged in food and agriculture industry* Engaged in preparation of proposals for prospective clients which were also converted into business to the firm* Guiding and mentoring junior team members on various valuation engagements

* Valuation of general insurance company operating in India for a possible investment by foreign insurance company in case the FDI limit in the insurance sector is increased* Purchase price allocation of healthcare business engaged in trading diagnostic in-vivo and in-vitro equipments and reagents in India* Valuation of portfolio companies operating in FMCG, seed manufacturing, hospital and healthcare sectors for a major PE fund * Valuation of an investee company of IL&FS operating an SEZ in south India for the proposed stake sale by IL&FS to another shareholder* Valuation of CFS and ICD business of a major listed company for the proposed acquisition by a major Japanese group* Supporting audit engagement teams in their impairment assessments (a truck & bus tyre manufacturing company, mid-size pharma company engaged in manufacturing saline solutions etc.)* Acting as auditor's expert in valuation of portfolio companies of global PE funds having investments in several real estate projects in India

* Worked on restructuring exercises involving valuation of multiple operating and non-operating companies with significant cross-holdings between the transacting companies;* Part of the team that dealt with the valuation of multiple listed and unlisted entities for the proposed composite scheme of amalgamation and demerger involving complexities related to treatment of employee stock options and share-warrants;* Worked on valuation of Economic Goodwill (~US$ 129 million) inherent within the business of a leading forgings company in India;* Worked on valuation engagements requiring determination of royalty fees for the use of specified brands by leading pharmaceutical company;* Dealt with valuation of Customer Contracts (~US$ 38 million) of an Italian company engaged in the business of manufacturing optic cables as a part of purchase price allocation exercise;* Single-handedly dealt with the allocation of the purchase price paid (INR 8,759.2 million) by a listed company for the acquisition of an auto-ancillary company - involving valuation of customer contracts, valuation of incentives and valuation of contingent liabilities;* Dispute valuation of a Noida-based bioanalytical testing and inspection related service provider based on underlying share purchase agreement;* Used various valuation methodologies such as Multi-period excess earnings method ('MPEEM'), With and Without method ('WWM') etc. for determining the value of intangible assets;* Worked on more than 30 diverse valuation engagements (regulatory – under Companies Act, Foreign Exchange Management Act etc. and non-regulatory) during one and a half year period;

• Part of Statutory Audit, Group Reporting, Quarterly review and Tax Audit engagements of multinational companies majorly from Pharmaceutical, Automobile manufacturing and Designing & Engineering sectors.• Pro-actively researched on possible business opportunities to the firm and prepared business proposals in consultation with Associate Directors and Directors.• Awarded with ‘Above and Beyond’ award for demonstrating exemplary performance and for outstanding contribution, which resulted in business advantage to the firm.